<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31121933</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>27</Day></DateCompleted><DateRevised><Year>2020</Year><Month>07</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>5</Issue><PubDate><Year>2019</Year><Month>May</Month><Day>22</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Enterovirus A71 VP1 Variation A289T Decreases the Central Nervous System Infectivity via Attenuation of Interactions between VP1 and Vimentin In Vitro and In Vivo.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">467</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v11050467</ELocationID><Abstract><AbstractText>Vimentin (VIM) is a surface receptor for enterovirus-A71, mediating the initial binding and subsequent increase in EV-A71 infectivity. The caspid protein VP1 variation, A289T, is reportedly closely associated with less severe central nervous system (CNS) infections in humans. However, it is unclear whether VIM is associated with a reduction in CNS infections of EV-A71 in the presence of A289T. We investigated whether VIM served as a receptor for EV-A71 in the presence of an A298T substitution in VP1. EV-A71-289A and EV-A71-289T were used to infect human rhabdomyosarcoma cells, control human brain microvascular endothelial cells (HBMECs), and VIM-knockout (KO) HBMECs and inoculated BALB/c mice, SV129 mice, and VIM-KO SV129 mice. Furthermore, we cloned VP1-289A-Flag and VP1-289T-Flag proteins for co-immunoprecipitation analysis. Analysis of viral function revealed that the capacity of viral attachment, replication, and protein synthesis and secretion decreased in HBMECs during an EV-A71-289A infection, the infectivity being higher than that of EV-A71-289T upon VIM-KO. Histopathological and immunohistochemical analyses of brain tissue revealed that cerebral cortical damage was more extensive in EV-A71-289A than in EV-A71-289T infections in control SV129 mice; however, no significant difference was observed upon VIM-KO. Co-immunoprecipitation analysis revealed an interaction between VP1 and VIM, which was attenuated in VP1 harboring A289T; however, this attenuation was reversed by VIM (1-58) peptide. The A289T variation of VP1 specifically decreased the virulence of EV-A71 in HBMECs, and the attenuated interaction between VP1 harboring the A289T variation and VIM essentially decreased the CNS infectivity of EV-A71 in vitro and vivo.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Huimin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, Southern Medical University, Guangzhou 510515, China. gg3612@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Yujuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, Southern Medical University, Guangzhou 510515, China. caoyujuan2090@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Weitao</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, Southern Medical University, Guangzhou 510515, China. swt937872090@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Shan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, Southern Medical University, Guangzhou 510515, China. 15625985968@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Weizhi</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, Southern Medical University, Guangzhou 510515, China. pigiraffe@126.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Yezhen</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, Southern Medical University, Guangzhou 510515, China. zhyezhen@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, Southern Medical University, Guangzhou 510515, China. mirrow2@i.smu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, Southern Medical University, Guangzhou 510515, China. zhaowei@smu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Bao</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, Southern Medical University, Guangzhou 510515, China. zhang20051005@126.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Xianbo</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, Southern Medical University, Guangzhou 510515, China. wuxb1010@hotmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>05</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036022">Capsid Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014746">Vimentin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036022" MajorTopicYN="N">Capsid Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002494" MajorTopicYN="N">Central Nervous System Infections</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019468" MajorTopicYN="N">Disease Management</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014644" MajorTopicYN="N">Genetic Variation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054884" MajorTopicYN="Y">Host-Pathogen Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014746" MajorTopicYN="N">Vimentin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014774" MajorTopicYN="N">Virulence</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">VP1 variation</Keyword><Keyword MajorTopicYN="N">central nervous system infectivity</Keyword><Keyword MajorTopicYN="N">enterovirus A71</Keyword><Keyword MajorTopicYN="N">vimentin</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31121933</ArticleId><ArticleId IdType="pmc">PMC6563288</ArticleId><ArticleId IdType="doi">10.3390/v11050467</ArticleId><ArticleId IdType="pii">v11050467</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wang S.M., Liu C.C. Enterovirus 71: Epidemiology, pathogenesis and management. Expert Rev. Anti Infect. Ther. 2009;7:735&#x2013;742. doi: 10.1586/eri.09.45.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/eri.09.45</ArticleId><ArticleId IdType="pubmed">19681701</ArticleId></ArticleIdList></Reference><Reference><Citation>Teoh H.L., Mohammad S.S., Britton P.N., Kandula T., Lorentzos M.S., Booy R., Jones C.A., Rawlinson W., Ramachandran V., Rodriguez M.L. Clinical Characteristics and Functional Motor Outcomes of Enterovirus 71 Neurological Disease in Children. JAMA Neurol. 2016;73:300&#x2013;307. doi: 10.1001/jamaneurol.2015.4388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2015.4388</ArticleId><ArticleId IdType="pubmed">26785318</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan L.G., Parashar U.D., Lye M.S., Ong F.G.L., Zaki S.R., Alexander J.P., Ho K.K., Han L.L., Pallansch M.A., Suleiman A.B., et al. Deaths of Children during an Outbreak of Hand, Foot, and Mouth Disease in Sarawak, Malaysia: Clinical and Pathological Characteristics of the Disease. Clin. Infect. Dis. 2000;31:678&#x2013;683. doi: 10.1086/314032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/314032</ArticleId><ArticleId IdType="pubmed">11017815</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K.Y. Enterovirus 71 infection and neurological complications. Korean J. Pediatr. 2016;59:395&#x2013;401. doi: 10.3345/kjp.2016.59.10.395.</Citation><ArticleIdList><ArticleId IdType="doi">10.3345/kjp.2016.59.10.395</ArticleId><ArticleId IdType="pmc">PMC5099286</ArticleId><ArticleId IdType="pubmed">27826325</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt N.J., Lennette E.H., Ho H.H. An Apparently New Enterovirus Isolated from Patients with Disease of the Central Nervous System. J. Infect. Dis. 1974;129:304&#x2013;309. doi: 10.1093/infdis/129.3.304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/129.3.304</ArticleId><ArticleId IdType="pubmed">4361245</ArticleId></ArticleIdList></Reference><Reference><Citation>Ping-Chin C., Shou-Chien C., Kow-Tong C. The Current Status of the Disease Caused by Enterovirus 71 Infections: Epidemiology, Pathogenesis, Molecular Epidemiology, and Vaccine Development. Int. J. Environ. Res. Public Health. 2016;13:890.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5036723</ArticleId><ArticleId IdType="pubmed">27618078</ArticleId></ArticleIdList></Reference><Reference><Citation>Shindarov L. Epidemiological, clinical and pathomorphological characteristics of epidemic poliomyelitis-like disease caused by enterovirus 71. J. Hyg. Epidemiol. Microbiol. Immunol. 1979;23:284.</Citation><ArticleIdList><ArticleId IdType="pubmed">231067</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy G., Tak&#xe1;tsy S., Kuk&#xe1;n E., Mih&#xe1;ly I., D&#xf6;m&#xf6;k I. Virological diagnosis of enterovirus type 71 infections: Experiences gained during an epidemic of acute CNS disease in Hungary in 1978. Arch. Virol. 1982;71:217&#x2013;227. doi: 10.1007/BF01314873.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01314873</ArticleId><ArticleId IdType="pubmed">6285858</ArticleId></ArticleIdList></Reference><Reference><Citation>Mcminn P., Lindsay K., Perera D., Chan H.M., Chan K.P., Cardosa M.J. Phylogenetic Analysis of Enterovirus 71 Strains Isolated during Linked Epidemics in Malaysia, Singapore, and Western Australia. J. Virol. 2001;75:7732&#x2013;7738. doi: 10.1128/JVI.75.16.7732-7738.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.75.16.7732-7738.2001</ArticleId><ArticleId IdType="pmc">PMC115010</ArticleId><ArticleId IdType="pubmed">11462047</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Tu P., Thao N.T.T., Perera D., Truong K.H., Tien N.T.K., Thuong T.C., How O.M., Cardosa M.J., Charles P. Peter Charles Epidemiologic and virologic investigation of hand, foot, and mouth disease, Southern Vietnam, 2005. Emerg. Infect. Dis. 2007;13:1733&#x2013;1741. doi: 10.3201/eid1311.070632.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1311.070632</ArticleId><ArticleId IdType="pmc">PMC3375788</ArticleId><ArticleId IdType="pubmed">18217559</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho M., Chen E.-R., Hsu K.-H., Twu S.-J., Wang J.-R., Shih S.-R., Chen K.-T., Tsai S.-F. An epidemic of enterovirus 71 infection in Taiwan. N. Engl. J. Med. 1999;341:929. doi: 10.1056/NEJM199909233411301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199909233411301</ArticleId><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain K.M., Leong K.L.J., Ng M.L., Chu J.J.H. The Essential Role of Clathrin-mediated Endocytosis in the Infectious Entry of Human Enterovirus 71. J. Biol. Chem. 2011;286:309&#x2013;321. doi: 10.1074/jbc.M110.168468.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.168468</ArticleId><ArticleId IdType="pmc">PMC3012988</ArticleId><ArticleId IdType="pubmed">20956521</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y., Shimojima M., Tano Y., Miyamura T., Wakita T., Shimizu H. Human p-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat. Med. 2009;15:794&#x2013;797. doi: 10.1038/nm.1961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1961</ArticleId><ArticleId IdType="pubmed">19543284</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S., Yamashita Y., Li J., Hanagata N., Minowa T., Takemura T., Koike S. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat. Med. 2009;15:798&#x2013;801. doi: 10.1038/nm.1992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1992</ArticleId><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Cong H., Du N., Hongchao T., Yang Y., Wei Z., Hua Z., Wenliang Z., Lei S., Po T. Enterovirus 71 VP1 Activates Calmodulin-Dependent Protein Kinase II and Results in the Rearrangement of Vimentin in Human Astrocyte Cells. PLoS ONE. 2013;8:e73900.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3779202</ArticleId><ArticleId IdType="pubmed">24073199</ArticleId></ArticleIdList></Reference><Reference><Citation>Challa A.A., Stefanovic B. A Novel Role of Vimentin Filaments: Binding and Stabilization of Collagen mRNAs. Mol. Cell. Biol. 2011;31:3773. doi: 10.1128/MCB.05263-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.05263-11</ArticleId><ArticleId IdType="pmc">PMC3165730</ArticleId><ArticleId IdType="pubmed">21746880</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi F., Jong T., Wang L., Ouyang Y., Wu C., Li W., Huang S.H. Vimentin-mediated signalling is required for IbeA+, E. coli, K1 invasion of human brain microvascular endothelial cells. Biochem. J. 2010;427:79&#x2013;90. doi: 10.1042/BJ20091097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20091097</ArticleId><ArticleId IdType="pubmed">20088823</ArticleId></ArticleIdList></Reference><Reference><Citation>Das S., Ravi V., Desai A. Japanese encephalitis virus interacts with vimentin to facilitate its entry into porcine kidney cell line. Virus Res. 2011;160:408. doi: 10.1016/j.virusres.2011.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2011.06.001</ArticleId><ArticleId IdType="pubmed">21798293</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn M., Desloges N., Rahaus M., Wolff M.H. Varicella-Zoster Virus Infection Influences Expression and Organization of Actin and &#x3b1;-Tubulin but Does Not Affect Lamin A and Vimentin. Intervirology. 2005;48:312&#x2013;320. doi: 10.1159/000085100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000085100</ArticleId><ArticleId IdType="pubmed">15956799</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei S., Tian Y.-P., Xiao W.-D., Li S., Rao X.-C., Zhang J.-L., Yang J., Hu X.-M., Chen W. ROCK is Involved in Vimentin Phosphorylation and Rearrangement Induced by Dengue Virus. Cell Biochem. Biophys. 2013;67:1333&#x2013;1342. doi: 10.1007/s12013-013-9665-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12013-013-9665-x</ArticleId><ArticleId IdType="pmc">PMC3838595</ArticleId><ArticleId IdType="pubmed">23737341</ArticleId></ArticleIdList></Reference><Reference><Citation>Du N., Cong H., Tian H., Zhang H., Zhang W., Song L., Tien P., Kirkegaard K. Cell Surface Vimentin Is an Attachment Receptor for Enterovirus 71. J. Virol. 2014;88:5816&#x2013;5833. doi: 10.1128/JVI.03826-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03826-13</ArticleId><ArticleId IdType="pmc">PMC4019121</ArticleId><ArticleId IdType="pubmed">24623428</ArticleId></ArticleIdList></Reference><Reference><Citation>Plevka P., Perera R., Yap M.L., Cardosa J., Kuhn R.J., Rossmann M.G. Structure of human enterovirus 71 in complex with a capsid-binding inhibitor. Proc. Natl. Acad. Sci. USA. 2013;110:5463&#x2013;5467. doi: 10.1073/pnas.1222379110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1222379110</ArticleId><ArticleId IdType="pmc">PMC3619292</ArticleId><ArticleId IdType="pubmed">23509286</ArticleId></ArticleIdList></Reference><Reference><Citation>Tee K.K., Lam T.T.-Y., Chan Y.F., Bible J.M., Kamarulzaman A., Tong C.Y.W., Takebe Y., Pybus O.G., Lam T.T.-Y. Evolutionary Genetics of Human Enterovirus 71: Origin, Population Dynamics, Natural Selection, and Seasonal Periodicity of the VP1 Gene. J. Virol. 2010;84:3339&#x2013;3350. doi: 10.1128/JVI.01019-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01019-09</ArticleId><ArticleId IdType="pmc">PMC2838098</ArticleId><ArticleId IdType="pubmed">20089660</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X., Zhong Y., Cao Y., Ke C., Guan D., Zhang B. Epidemiological characteristics and virulence of EV71 in Guangdong province. J. Pract. Med. 2015 doi: 10.3969/j.issn.1006-5725.2015.06.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.3969/j.issn.1006-5725.2015.06.044</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y.L., Wu X.Y., Qin C.F., Zhang Y., Wu X.Y., He Y.L., Qin C., Chen R. Human Enterovirus 71 Uncoating Captured at Atomic Resolution. J. Virol. 2014;88:3114&#x2013;3126.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3957924</ArticleId><ArticleId IdType="pubmed">24352461</ArticleId></ArticleIdList></Reference><Reference><Citation>Baochang F., Peiying Y. Reverse genetic manipulation on RNA virus. Bull. Acad. Mil. Med. Sci. 2001:25.</Citation></Reference><Reference><Citation>Arita M., Nagata N., Iwata N., Ami Y., Suzaki Y., Mizuta K., Iwasaki T., Sata T., Wakita T., Shimizu H. An Attenuated Strain of Enterovirus 71 Belonging to Genotype A Showed a Broad Spectrum of Antigenicity with Attenuated Neurovirulence in Cynomolgus Monkeys. J. Virol. 2007;81:9386&#x2013;9395. doi: 10.1128/JVI.02856-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02856-06</ArticleId><ArticleId IdType="pmc">PMC1951441</ArticleId><ArticleId IdType="pubmed">17567701</ArticleId></ArticleIdList></Reference><Reference><Citation>Liou A.-T., Wu S.-Y., Liao C.-C., Chang Y.-S., Chang C.-S., Shih C. A new animal model containing human SCARB2 and lacking stat-1 is highly susceptible to EV71. Sci. Rep. 2016;6:31151. doi: 10.1038/srep31151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep31151</ArticleId><ArticleId IdType="pmc">PMC4976353</ArticleId><ArticleId IdType="pubmed">27499235</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Z., Li H., Yang T., Zhengling L., Min F., Tianhong X., Runxiang L., Dong S., Guangju J., Lei Y., et al. Biological characteristics of different epidemic enterovirus 71 strains and their pathogeneses in neonatal mice and rhesus monkeys. Virus Res. 2016;213:82&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">26555165</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y.F., Yu C.K. Animal models of enterovirus 71 infection: Applications and limitations. J. Biomed. Sci. 2014;21:31. doi: 10.1186/1423-0127-21-31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-21-31</ArticleId><ArticleId IdType="pmc">PMC4013435</ArticleId><ArticleId IdType="pubmed">24742252</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang G.-H., Lin L., Luo Y.-J., Cai L.-J., Wu X.-Y., Xu H.-M., Zhu Q.-Y. Sequence analysis of six enterovirus 71 strains with different virulences in humans. Virus Res. 2010;151:0&#x2013;73. doi: 10.1016/j.virusres.2010.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2010.04.001</ArticleId><ArticleId IdType="pubmed">20398708</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M., Ami Y., Wakita T., Shimizu H. Cooperative effect of the attenuation determinants derived from poliovirus sabin 1 strain is essential for attenuation of enterovirus 71 in the NOD/SCID mouse infection model. J. Virol. 2008;82:1787. doi: 10.1128/JVI.01798-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01798-07</ArticleId><ArticleId IdType="pmc">PMC2258712</ArticleId><ArticleId IdType="pubmed">18057246</ArticleId></ArticleIdList></Reference><Reference><Citation>Afonso P.V., Ozden S., Cumont M.-C., Seilhean D., Cartier L., Rezaie P., Mason S., Lambert S., Huerre M., Gessain A., et al. Alteration of Blood&#x2013;Brain Barrier Integrity by Retroviral Infection. PLoS Pathog. 2008;4:e1000205. doi: 10.1371/journal.ppat.1000205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000205</ArticleId><ArticleId IdType="pmc">PMC2575404</ArticleId><ArticleId IdType="pubmed">19008946</ArticleId></ArticleIdList></Reference><Reference><Citation>Stins M.F., Badger J., Kim K.S. Bacterial invasion and transcytosis in transfected human brain microvascular endothelial cells. Microb. Pathog. 2001;30:19&#x2013;28. doi: 10.1006/mpat.2000.0406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/mpat.2000.0406</ArticleId><ArticleId IdType="pubmed">11162182</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P., Song Z., Qi Y., Feng X., Xu N., Sun Y., Wu X., Yao X., Mao Q., Li X., et al. Molecular Determinants of Enterovirus 71 Viral Entry. J. Biol. Chem. 2012;287:6406&#x2013;6420. doi: 10.1074/jbc.M111.301622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.301622</ArticleId><ArticleId IdType="pmc">PMC3307280</ArticleId><ArticleId IdType="pubmed">22219187</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyousuke K., Sudaka Y., Takashino A., Imura A., Fujii K., Koike S. Amino acid variation at VP1-145 of enterovirus 71 determines attachment receptor usage and neurovirulence in human scavenger receptor B2 transgenic mice. J. Virol. 2018;92:e00681-18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6052303</ArticleId><ArticleId IdType="pubmed">29848584</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao H.S., Xie Q., Zhong J.Y., Gerald B.R., He X.L., Qu Y.L., Cao H. Effect of vimentin on activation of NLRP3 inflammasome in the brain of mice with EV71 infection. J. South. Med. Univ. 2018;38:704&#x2013;710.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6765721</ArticleId><ArticleId IdType="pubmed">29997093</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>